Stay updated on Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The completed psoriasis study record is now displayed, including its safety and efficacy objectives, eligibility criteria, outcomes, study locations, and data-sharing details.
    Difference
    100%
    Check dated 2026-11-08T00:30:06.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T18:35:16.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A notification banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T20:32:27.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The revision label in the footer changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T20:35:24.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0; the study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:43:09.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, replacing the study content with a simple error layout and a Home button. The detailed study information and navigation are no longer visible due to access restrictions.
    Difference
    16%
    Check dated 2026-09-19T19:21:58.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.